期刊文献+

Ki67、Ck19与肝细胞癌临床病理特征和磁共振成像表观扩散系数的相关性分析 被引量:12

Correlation analysis of Ki67,Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma
原文传递
导出
摘要 目的探讨细胞增殖核抗原(Ki67)、细胞角蛋白19(Ck19)在肝细胞癌(HCC)中的表达,研究其与HCC临床病理特征和磁共振成像表观扩散系数(ADC)值的相关性。方法回顾性收集2014年1月至2019年10月在郑州大学附属肿瘤医院就诊的203例HCC初诊患者的资料,分析所有患者癌组织中Ki67及Ck19的表达和ADC值,以及Ki67和Ck19与患者临床病理特征的关系,并计算与ADC值的差异及相关性。结果Ki67表达阳性和阴性组间的HCC脉管癌栓、甲胎蛋白(AFP)、肿瘤分化程度、复发、淋巴结转移差异有统计学意义(χ^(2)=5.156、12.741、29.925、3.963、77.408,均P<0.05),与ADC值呈负相关(r=-0.214,P=0.002),低Ki67组患者HCC肿瘤的平均ADC值明显高于高Ki67组(1089±280比1009±212,P<0.05);Ck19表达阳性、阴性组间脉管癌栓、AFP、复发、淋巴结转移差异有统计学意义(χ^(2)=9.058、27.034、4.053、14.187,均P<0.05),与ADC值无相关性(r=0.062,P=0.380)。Ki67、Ck19表达在HCC复发时间不同分组之间的差异有统计学意义(均P<0.05)。结论Ki67及Ck19在HCC中的异常表达与HCC术后预后、复发有相关性。Ck19与ADC值之间无相关性,Ki67与ADC值呈负相关,提示ADC值对于术前HCC生物学特性能够提供一定的影像学依据。 Objective To investigate the expression of cell proliferating nuclear antigen(Ki67)and cytokeratin 19(Ck19)in hepatocellular carcinoma(HCC),and correlation with the clinicopathological features and apparent diffusion coefficient(ADC)value of hepatocellular carcinoma.Methods The data of 203 newly diagnosed HCC patients in the Affiliated Cancer Hospital of Zhengzhou University from January 2014 to October 2019 were retrospectively collected,and the expression of Ki67 and Ck19 and ADC values in all patients were analyzed.The relationship between Ki67 and Ck19 and the clinical pathological characteristics of the patient,and calculate the difference and correlation with the ADC value was analyzed.Results There were statistically significant differences in tumor vascular tumor thrombus,alpha-fetoprotein(AFP),postoperative tumor recurrence,lymph node metastasis,and HCC differentiation between Ki67 positive and negative groups(χ^(2)=5.156,12.741,29.925,3.963,77.408,all P<0.05),and negatively correlated with ADC value(r=-0.214,P=0.002).The average ADC value of HCC in the low Ki67 group was significantly higher than that of the high Ki67 group(1089±280 vs 1009±212,P<0.05).There were statistically significant differences in tumor vascular tumor thrombus,AFP,postoperative tumor recurrence,and lymph node metastasis between Ck19 positive and negative groups(χ^(2)=9.058,27.034,4.053,14.187,all P<0.05),but not correlated with ADC value(r=0.062,P=0.380).The expression differences of Ki67 and Ck19 in different HCC recurrence time groups were statistically significant(P<0.05).Conclusion The positive expression of Ki67 and Ck19 in HCC was associated with the prognosis and recurrence of HCC.CK19 was not correlated with the ADC value,while Ki67 was negatively correlated with the ADC value,indicating that ADC value could provide certain imaging information for the biological characteristics of preoperative HCC.
作者 韩帅 孟帆 张宏凯 黎海亮 曲金荣 Han Shuai;Meng Fan;Zhang Hongkai;Li Hailiang;Qu Jinrong(Department of Radiology,Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zheng zhou 450008,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2021年第11期798-802,共5页 National Medical Journal of China
基金 河南省卫生健康科技创新领军人才培养项目(YXKC2020011) 河南省卫生计生科技创新型人才“51282”工程领军人才(20160913)。
关键词 肝细胞 KI67 CK19 弥散 Carcinoma,hepatocellular Ki67 Ck19 DWI
  • 相关文献

参考文献7

二级参考文献54

  • 1Petra G Kele,Eric J van der Jagt.Diffusion weighted imaging in the liver[J].World Journal of Gastroenterology,2010,16(13):1567-1576. 被引量:48
  • 2丛文铭,吴孟超,陈汉,张秀忠,董秀芬.DNA含量分析对复发性肝细胞癌克隆来源及其临床意义的初步研究[J].临床肝胆病杂志,1993,9(1):3-5. 被引量:26
  • 3丛文铭,吴孟超.小肝细胞癌的临床病理特点:附93例分析[J].中华肿瘤杂志,1993,15(5):372-374. 被引量:35
  • 4Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future pros- pects. Semin Liver Dis 2010; 30:61-74.
  • 5Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebou- issou S, Jeannot E, H6rault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. Transcrip- tome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45:42-52.
  • 6Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, Shibata T. Geneti- cally distinct and clinically relevant classification of hepato- cellular carcinoma: putative therapeutic targets. Gastroenter- ology 2007; 133:1475-1486.
  • 7Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3:S228-S234.
  • 8Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO clas- sification of tumours of the digestive system. 4th ed. Lyon: IARC, 2010.
  • 9Lu XY, Xi T, Lau WY, Dong H, Zhu Z, Shen F, Wu MC, Cong WM. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behav- ior. Ann Surg Onco12011; 18:2210-2217.
  • 10Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D. Combined he- patocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94:2040-2046.

共引文献51

同被引文献116

引证文献12

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部